VALIDATION OF A POPULATION PHARMACOKINETIC MODEL OF SUBCUTANEOUS IMMUNOGLOBULIN (IGPRO20) AFTER WEEKLY AND BIWEEKLY DOSING IN PRIMARY IMMUNODEFICIENCY PATIENTS.

Zhang Y.; Baheti G.; Rojavin M.; Praus M.; Tortorici M.; Jochems J.; Sidhu J.

首页> 外文期刊>Clinical Pharmacology and Therapeutics >VALIDATION OF A POPULATION PHARMACOKINETIC MODEL OF SUBCUTANEOUS IMMUNOGLOBULIN (IGPRO20) AFTER WEEKLY AND BIWEEKLY DOSING IN PRIMARY IMMUNODEFICIENCY PATIENTS.

【24h】

VALIDATION OF A POPULATION PHARMACOKINETIC MODEL OF SUBCUTANEOUS IMMUNOGLOBULIN (IGPRO20) AFTER WEEKLY AND BIWEEKLY DOSING IN PRIMARY IMMUNODEFICIENCY PATIENTS.

机译：原发性免疫缺陷患者每周和双周给药后皮下免疫球蛋白（IGPRO20）的人口药代动力学模型。

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Clinical Pharmacology and Therapeutics》 |2018年第1期|共1页
作者
Zhang Y.; Baheti G.; Rojavin M.; Praus M.; Tortorici M.; Jochems J.; Sidhu J.;
展开▼
作者单位

CSL Behring King Of Prussia PA USA;

CSL Behring King Of Prussia PA USA;

CSL Behring King Of Prussia PA USA;

CSL Behring Marburg Germany;

CSL Behring King Of Prussia PA USA;

CSL Behring King Of Prussia PA USA;

CSL Ltd Parkville Vic Australia;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词

相似文献

外文文献
中文文献
专利

1. VALIDATION OF A POPULATION PHARMACOKINETIC MODEL OF SUBCUTANEOUS IMMUNOGLOBULIN (IGPRO20) AFTER WEEKLY AND BIWEEKLY DOSING IN PRIMARY IMMUNODEFICIENCY PATIENTS. [J] . Zhang Y., Baheti G., Rojavin M., Clinical Pharmacology and Therapeutics . 2018,第Suppla1期

机译：原发性免疫缺陷患者每周和双周给药后皮下免疫球蛋白（IGPRO20）的人口药代动力学模型。
2. Population pharmacokinetic analysis of weekly and biweekly IgPro20 (Hizentra (R)) dosing in patients with primary immunodeficiency [J] . Zhang Ying, Baheti Gautam, Chapdelaine Hugo, International immunopharmacology . 2020,第1期

机译：初级免疫缺陷患者每周和双周IgPro20（Hizentra（R））的人口药代动力学分析
3. Population pharmacokinetic modeling and simulation of immunoglobulin exposure with varying dosing intervals of subcutaneous immunoglobulin 20% (Ig20Gly) in patients with primary immunodeficiency diseases [J] . Dumas Todd, Berry N. Seth, Wolfsegger Martin, International immunopharmacology . 2019,第期

机译：初级免疫缺陷患者皮下免疫球蛋白20％（Ig20gly）不同给药间隔的人口药代动力学建模与仿真性间隔
4. Standards of treatment with subcutaneous immunoglobulins in primary immunodeficiencies –guidelines for doctors and nurses drawn up by three immunology centers in Poland. [C] . Lewowicz-Uszyńska A., Szaflarska A., Pietrucha B., European Society Immunodeficiencies., Meeting. . 2013

机译：初级免疫植物中皮下免疫球蛋白的治疗标准 - 在波兰三次免疫中心制定的医生和护士。
5. Clinical pharmacokinetic simulation/modeling as a tool for therapeutic drug monitoring and dose adjustment in special patient populations. [D] . Mohamed, Osama H. 2004

机译：临床药代动力学模拟/建模，作为特殊患者人群中治疗药物监测和剂量调整的工具。
6. Enhancing Patient Flexibility of Subcutaneous Immunoglobulin G Dosing: Pharmacokinetic Outcomes of Various Maintenance and Loading Regimens in the Treatment of Primary Immunodeficiency [O] . Jagdev Sidhu, Mikhail Rojavin, Marc Pfister, 2014

机译：增强患者皮下免疫球蛋白G剂量的灵活性：各种维持和负荷方案在原发性免疫缺陷治疗中的药代动力学结果
7. Enhancing Patient Flexibility of Subcutaneous Immunoglobulin G Dosing: Pharmacokinetic Outcomes of Various Maintenance and Loading Regimens in the Treatment of Primary Immunodeficiency [O] . 2014

机译：增强患者皮下免疫球蛋白G剂量的灵活性：各种维持和负荷方案在原发性免疫缺陷治疗中的药代动力学结果

VALIDATION OF A POPULATION PHARMACOKINETIC MODEL OF SUBCUTANEOUS IMMUNOGLOBULIN (IGPRO20) AFTER WEEKLY AND BIWEEKLY DOSING IN PRIMARY IMMUNODEFICIENCY PATIENTS.

著录项

引文网络

相似文献

相关主题

期刊订阅